These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20009580)

  • 1. Developmental strategies for evasion of Arf tumor suppression.
    Volanakis EJ; Sherr CJ
    Cell Cycle; 2010 Jan; 9(1):14-5. PubMed ID: 20009580
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia.
    Volanakis EJ; Williams RT; Sherr CJ
    Blood; 2009 Nov; 114(20):4451-9. PubMed ID: 19759355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.
    Volanakis EJ; Boothby MR; Sherr CJ
    Exp Hematol; 2013 Apr; 41(4):377-86. PubMed ID: 23178376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.
    Treanor LM; Volanakis EJ; Zhou S; Lu T; Sherr CJ; Sorrentino BP
    Blood; 2011 May; 117(20):5453-62. PubMed ID: 21427293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss.
    Medyouf H; Gao X; Armstrong F; Gusscott S; Liu Q; Gedman AL; Matherly LH; Schultz KR; Pflumio F; You MJ; Weng AP
    Blood; 2010 Feb; 115(6):1175-84. PubMed ID: 20008304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Notch1 promotes development of human CD8(+) single positive T cells in humanized mice.
    Haji Y; Suzuki M; Moriya K; So T; Hozumi K; Mizuma M; Unno M; Ishii N
    Biochem Biophys Res Commun; 2014 May; 447(2):346-51. PubMed ID: 24726647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
    Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
    J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct sensitivity of CD8+ CD4- and CD8+ CD4+ leukemic cell subpopulations to cyclophosphamide and rapamycin in Notch1-induced T-ALL mouse model.
    Zhang Y; Hua C; Cheng H; Wang W; Hao S; Xu J; Wang X; Gao Y; Zhu X; Cheng T; Yuan W
    Leuk Res; 2013 Nov; 37(11):1592-601. PubMed ID: 24090996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The characteristics and prognostic impact of NOTCH1/FBXW7 mutation and CDKN2A/B deletion in adult T-cell acute lymphoblastic leukemia patients].
    Fang QY; Hao QS; Gong XY; Wang J; Li QH; Yuan T; Tian Z; Liu KQ; Li Y; Liu YT; Gong BF; Wang Y; Wei H; Zhou CL; Lin D; Liu BC; Wei SN; Zhang GJ; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):432-435. PubMed ID: 34218589
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetic targeting of Notch1-driven transcription using the HDACi panobinostat is a potential therapy against T-cell acute lymphoblastic leukemia.
    Waibel M; Vervoort SJ; Kong IY; Heinzel S; Ramsbottom KM; Martin BP; Hawkins ED; Johnstone RW
    Leukemia; 2018 Jan; 32(1):237-241. PubMed ID: 28914259
    [No Abstract]   [Full Text] [Related]  

  • 11. T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.
    Cancer Discov; 2014 Nov; 4(11):OF17. PubMed ID: 25367958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.
    Gianni F; Belver L; Ferrando A
    Cold Spring Harb Perspect Med; 2020 Mar; 10(3):. PubMed ID: 31570389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX3X-MLLT10 fusion in adults with NOTCH1 positive T-cell acute lymphoblastic leukemia.
    Brandimarte L; La Starza R; Gianfelici V; Barba G; Pierini V; Di Giacomo D; Cools J; Elia L; Vitale A; Luciano L; Bardi A; Chiaretti S; Matteucci C; Specchia G; Mecucci C
    Haematologica; 2014 May; 99(5):64-6. PubMed ID: 24584351
    [No Abstract]   [Full Text] [Related]  

  • 14. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia.
    Mirandola L; Chiriva-Internati M; Montagna D; Locatelli F; Zecca M; Ranzani M; Basile A; Locati M; Cobos E; Kast WM; Asselta R; Paraboschi EM; Comi P; Chiaramonte R
    J Pathol; 2012 Apr; 226(5):713-22. PubMed ID: 21984373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development.
    de Bock CE; Down M; Baidya K; Sweron B; Boyd AW; Fiers M; Burns GF; Molloy TJ; Lock RB; Soulier J; Taghon T; Van Vlierberghe P; Cools J; Holst J; Thorne RF
    Haematologica; 2019 May; 104(5):e204-e207. PubMed ID: 30514801
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
    Rao SS; O'Neil J; Liberator CD; Hardwick JS; Dai X; Zhang T; Tyminski E; Yuan J; Kohl NE; Richon VM; Van der Ploeg LH; Carroll PM; Draetta GF; Look AT; Strack PR; Winter CG
    Cancer Res; 2009 Apr; 69(7):3060-8. PubMed ID: 19318552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NOTCH1/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model.
    García-Peydró M; Fuentes P; Mosquera M; García-León MJ; Alcain J; Rodríguez A; García de Miguel P; Menéndez P; Weijer K; Spits H; Scadden DT; Cuesta-Mateos C; Muñoz-Calleja C; Sánchez-Madrid F; Toribio ML
    J Clin Invest; 2018 Jul; 128(7):2802-2818. PubMed ID: 29781813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin C surprises in tumour suppression.
    Trakala M; Malumbres M
    Nat Cell Biol; 2014 Nov; 16(11):1031-3. PubMed ID: 25358351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEST domain NOTCH mutations confer a poor relapse free survival in pediatric T-ALL: Data from a tertiary care centre in India.
    Bhatia P; Totadri S; Singh M; Sharma P; Trehan A; Bansal D; Jain R; Varma N; Sachdeva MS; Patra N
    Blood Cells Mol Dis; 2020 May; 82():102419. PubMed ID: 32179411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.
    Genescà E; Lazarenkov A; Morgades M; Berbis G; Ruíz-Xivillé N; Gómez-Marzo P; Ribera J; Juncà J; González-Pérez A; Mercadal S; Guardia R; Artola MT; Moreno MJ; Martínez-López J; Zamora L; Barba P; Gil C; Tormo M; Cladera A; Novo A; Pratcorona M; Nomdedeu J; González-Campos J; Almeida M; Cervera J; Montesinos P; Batlle M; Vives S; Esteve J; Feliu E; Solé F; Orfao A; Ribera JM
    J Hematol Oncol; 2018 Jul; 11(1):96. PubMed ID: 30041662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.